Regeneron Pharmaceuticals (REGN) FCF Payout Ratio (2025 - 2026)
Regeneron Pharmaceuticals (REGN) recorded quarterly FCF Payout Ratio of 0.12 in Q1 2026, up 14.67% quarter-over-quarter from 0.1 in Q4 2025, and little changed on a YoY basis from 0.11 in Q1 2025.
Regeneron Pharmaceuticals (REGN) FCF Payout Ratio (2025 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' FCF Payout Ratio history runs 2 years deep, the most recent figure standing at 0.12 for Q1 2026.
- In Q1 2026, FCF Payout Ratio changed 0.27% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.09 (up 200.93% YoY), while the FY2025 annual figure was 0.09, changed N/A from the prior year.
- FCF Payout Ratio was 0.12 for Q1 2026 at Regeneron Pharmaceuticals, up from 0.1 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 0.12 in Q1 2026 to a low of 0.08 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.11 |